ExMediKA
ActiveSummary
ExMediKA has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €275,693 and a net result of €94,786. Equity is growing by ~52.2% per year across the filed fiscal years. Its solvency ranks better than 72% of 4266 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
31-10
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
31-03
Financial
Highest result since 2023net €94,786 ▲0.7%
Operating result €133,341, net result €94,786, both a record.
31-03
Financial
Equity above €200,000Eq €275,693 ▲52.4%
3 profitable years in a row build equity to €275,693.
2024
28-11
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 28 days late
31-03
Financial
Equity above €150,000Eq €180,907 ▲109%
2 profitable years in a row build equity to €180,907.
2023
17-11
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 17 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.